Hypohidrotic Ectodermal Dysplasia (HED)

Hypohidrotic ectodermal dysplasia is a rare genetic condition that affects body parts that come from the outer layer of the embryo (the ectoderm). These parts include the skin, hair, nails, teeth, and sweat glands. In HED, these structures do not form in the usual way before birth. As a result, many children and adults with HED have very little or no sweating (hypohidrosis/anhidrosis), fewer or missing teeth (hypodontia), and thin, sparse hair (hypotrichosis). Because sweating helps control body temperature, people with HED can overheat, especially during hot weather, fever, or exercise. The condition ranges from mild to severe and can affect males and females, though the most common form is X-linked, which tends to be more severe in males. The underlying problem is a change (mutation) in one of a small group of genes (most often EDA, EDAR, EDARADD, or WNT10A) that are needed for normal signaling during the early formation of hair follicles, sweat glands, and teeth. MedlinePlus+3NCBI+3MedlinePlus+3

Hypohidrotic ectodermal dysplasia (HED) is a rare, inherited condition that mainly affects the sweat glands, teeth, hair, skin, and nails. Most people with HED have reduced sweating (hypohidrosis), few or missing teeth (hypodontia) with small or pointed teeth, and sparse, thin hair (hypotrichosis). Because sweating is poor or absent, overheating and heat illness can happen easily, especially in babies and small children. HED is usually caused by changes in one of four genes—EDA, EDAR, EDARADD, or WNT10A—with the X-linked EDA form being the most common. Diagnosis is based on typical features plus genetic testing. Treatment is supportive and preventive: strict heat control, early and ongoing dental care, eye and skin care, and routine management of infections or allergies. There is no FDA-approved, disease-modifying drug for HED; prenatal replacement of EDA protein is investigational only. New England Journal of Medicine+3NCBI+3NCBI+3

Other names

HED is also known by several other names that may appear in clinic notes or papers:

• Anhidrotic ectodermal dysplasia (used when sweating is nearly absent).

• X-linked hypohidrotic ectodermal dysplasia (XLHED) when the EDA gene on the X chromosome is involved.

• Autosomal dominant/recessive hypohidrotic ectodermal dysplasia when EDAR, EDARADD, or WNT10A are involved.

• Historical synonyms include Christ–Siemens–Touraine syndrome (now less preferred). NCBI+1

Types

HED is grouped by inheritance pattern and the gene involved:

1. X-linked HED (XLHED) – caused by pathogenic variants in EDA (ectodysplasin A). Males typically have the classic triad (reduced sweating, sparse hair, missing teeth); female carriers can have milder features due to X-inactivation. NCBI+1

2. Autosomal dominant HED – usually due to variants in EDAR, EDARADD, or WNT10A; each child has a 50% chance to inherit the change. Severity varies. NCBI

3. Autosomal recessive HED – occurs when a child inherits two non-working copies of EDAR, EDARADD, or WNT10A; parents are typically unaffected carriers. NCBI

4. Syndromic/overlap forms – rare associations where HED features occur with other organ findings (for example, rare HED-hypothyroidism-ciliary dyskinesia associations). These are uncommon but documented. Orpha

---

Causes

These “causes” are different genetic mechanisms and pathways that can lead to the same outward HED features. Each item explains what the cause is and how it leads to symptoms.

1. EDA gene variants (XLHED) – Changes in the EDA gene disrupt the ectodysplasin A protein, which normally sends signals that start hair follicles, teeth, and sweat glands during early development; without this signal, these structures remain underdeveloped or absent. NCBI+1

2. EDAR gene variants – EDAR is the receptor for ectodysplasin; damaging variants break the message-receiving step of the same pathway, producing the classic HED triad. MedlinePlus

3. EDARADD gene variants – EDARADD is an adaptor that links the EDAR receptor to downstream signals; if it is faulty, the pathway cannot activate properly. NCBI

4. WNT10A gene variants – WNT10A is part of a separate but cooperating signaling system (WNT) essential for tooth and hair development; variants can cause HED or HED-like features with missing teeth and dental shape changes. MedlinePlus

5. Large deletions/duplications affecting EDA/EDAR/EDARADD/WNT10A – Copy-number changes that remove or duplicate key parts of these genes can silence the pathway similarly to point mutations. NCBI

6. Mosaicism in EDA (often in carrier females) – When only some cells carry the variant, features may be patchy (e.g., lines of decreased sweat pores on the skin), leading to variable expression. NCBI

7. Missense vs. truncating mutations – The type of variant can influence severity; protein-truncating variants often cause more severe sweat gland absence than some missense changes. NCBI

8. Pathway disruption during a narrow developmental window – The EDA/EDAR/NF-κB pathway acts early in skin appendage “placode” formation; if signaling is absent at that time, organs never form, leading to lifelong hypohidrosis and hypodontia. NCBI

9. X-linked inheritance in XLHED – Because males have one X chromosome, a single EDA variant can fully manifest; females (two X chromosomes) may have milder findings due to random X-inactivation, explaining family patterns. Orpha

10. Autosomal dominant transmission (EDAR/EDARADD/WNT10A) – A single changed copy can be enough to reduce signaling below the threshold needed for normal hair, tooth, and sweat gland development. NCBI

11. Autosomal recessive transmission – Two faulty copies (one from each parent) are required; carriers may have subtle or no symptoms, but affected children can have classic HED. NCBI

12. Pathogenic variants altering ligand–receptor binding – Some EDA or EDAR changes specifically prevent protein–protein binding, blocking the initiation of the signal cascade. NCBI

13. Variants that impair NF-κB activation – Downstream of EDAR/EDARADD, the NF-κB pathway turns on genes needed for appendage formation; variants that reduce this activation lead to ectodermal organ hypoplasia/aplasia. NCBI

14. Variants affecting ectodysplasin processing/secretion – EDA must be correctly processed and secreted; defects in these steps reduce signal availability to the EDAR receptor. NCBI

15. Splice-site variants – Changes that disrupt normal RNA splicing can remove critical protein domains in EDA/EDAR/EDARADD, again blocking signaling. NCBI

16. Regulatory region variants – Rare changes outside coding regions can down-regulate EDA-pathway genes during development, mimicking coding-region mutations. NCBI

17. Compound heterozygosity – Two different variants in the same autosomal gene (e.g., EDAR) inherited from each parent can combine to produce HED. NCBI

18. Gene–gene interactions (EDA and WNT networks) – Parallel signaling (EDA/NF-κB and WNT) jointly pattern tooth and hair development; disruption in one can magnify defects when the other is borderline. MedlinePlus

19. De novo variants – Some individuals have a new (not inherited) mutation in one of the HED genes, explaining isolated cases without parental findings. NCBI

20. Extremely rare syndromic gene defects with HED features – Rare reports describe HED traits alongside other organ issues (e.g., ciliary dysfunction), reflecting broader developmental signaling disturbances. Orpha

---

Symptoms and signs

1. Reduced or absent sweating (hypohidrosis/anhidrosis) – People feel hot easily, cannot tolerate heat, and may have dangerously high fevers; skin may be dry because sweat glands are few or absent. NCBI+1

2. Overheating (hyperthermia) episodes – Especially in infancy, heat stress can be severe because the body cannot cool through sweating. Caregivers often report unexplained high fevers. Ektodermale Dysplasie

3. Missing or fewer teeth (hypodontia/oligodontia) – Many permanent teeth never form; the teeth that do erupt may be small, cone-shaped, or widely spaced, affecting chewing and speech. MedlinePlus

4. Thin, sparse scalp and body hair (hypotrichosis) – Hair is often light, slow-growing, and sparse; eyebrows and eyelashes may also be thin. PubMed

5. Dry skin (xerosis) and eczema-like irritation – With fewer sweat and sebaceous glands, the skin barrier is dry and prone to cracking or itching. GARD Information Center

6. Reduced tears and dry eyes – Some individuals have decreased tear production, causing irritation, light sensitivity, and recurrent conjunctival symptoms. NCBI

7. Dry mouth and reduced saliva – Leads to dental caries risk, oral discomfort, and difficulty swallowing dry foods. NCBI

8. Typical facial features – Midface may appear flatter, with a saddle-shaped nose, full everted lips, and periorbital wrinkling; these reflect reduced skin appendages and bone/dental development changes. NCBI

9. Nail changes – Nails can be thin, brittle, or grow slowly, though nail involvement varies by gene. MedlinePlus

10. Recurrent respiratory issues – Thick nasal secretions and dry airways can cause crusting, nosebleeds, and infections. GARD Information Center

11. Heat intolerance with exercise – Physical activity may trigger flushing, dizziness, or headaches due to poor thermoregulation. MDPI

12. Feeding and growth challenges in infancy – Because of overheating, oral dryness, and dental differences, some infants may feed poorly and need careful temperature control. NCBI

13. Sinus and ear problems – Dry mucosa can predispose to sinusitis and otitis in some individuals. GARD Information Center

14. Psychosocial impact – Dental differences and hair sparsity may affect self-esteem and social interactions, especially in school years. GARD Information Center

15. Female carriers with mild features – Women who carry an EDA variant can show patchy reduced sweat pores, slight dental anomalies, or mild hair changes due to X-inactivation patterns. NCBI

---

Diagnostic tests

A) Physical examination

1. Comprehensive dermatologic exam – Clinician looks for sparse hair, decreased body hair, dry skin, reduced sweat pore visibility, and periorbital wrinkling. These visible signs raise suspicion for HED when combined with heat intolerance. NCBI

2. Temperature/heat-tolerance observation – Noting flushing, lack of sweating, and overheating during mild exertion or in warm rooms supports the diagnosis of hypohidrosis. MDPI

3. Dental examination (primary and permanent teeth) – Counting missing teeth, noting peg-shaped incisors/canines, and evaluating occlusion and enamel status provide early, objective clues. MedlinePlus

4. Hair examination (scalp, eyebrows, lashes) – Assessing density, caliber, and growth pattern documents hypotrichosis typical of HED. PubMed

5. ENT exam of mucosa – Dry nasal and oral mucosa with crusting suggests reduced gland function, supporting the pattern of ectodermal gland hypoplasia. GARD Information Center

B) Manual/bedside tests

6. Iodine–starch sweat print (Minor test) – A simple bedside test where iodine and starch applied to the skin turn dark in areas that sweat; in HED, staining is reduced or absent, showing few active sweat glands. PMC

7. Thermoregulatory Sweat Test (TST) – The whole body is dusted with indicator powder and warmed in a controlled setting; patterns of sweating are photographed. HED typically shows widespread anhidrosis or patchy hypohidrosis. PMC+1

8. Schirmer tear test – Small paper strips placed under the lower eyelids measure tear production; reduced wetting supports dry-eye related to gland hypofunction. NCBI

9. Simple salivary flow (sialometry) – Timed saliva collection quantifies resting and stimulated flow; low output supports reduced salivary gland function. NCBI

10. Tooth eruption charts with clinical photographs – Tracking delayed or absent eruption against age norms helps document dental agenesis typical in HED. MedlinePlus

C) Laboratory & pathology

11. Molecular genetic testing (single-gene, gene panel, or exome) – Identifies pathogenic variants in EDA, EDAR, EDARADD, or WNT10A, confirming the diagnosis and guiding genetic counseling and, in some settings, prenatal options. NCBI+1

12. Carrier testing for at-risk females (EDA sequencing/CNV) – Detects the familial variant; helpful for family planning and understanding variable features in female relatives. NCBI

13. Skin biopsy with histology – May show reduced or absent eccrine sweat glands and hair follicles, directly documenting the structural basis of hypohidrosis and hypotrichosis. NCBI

14. Prenatal genetic diagnosis (CVS/amniocentesis) – If the familial variant is known, fetal testing can determine whether the fetus is affected or a carrier, which can inform delivery planning and, in some centers, consideration of investigational therapies. NCBI+1

15. Tooth-germ sonography in carrier pregnancies (research/advanced centers) – Prenatal ultrasound can visualize missing fetal tooth germs in XLHED, serving as a noninvasive marker when EDA variants are present. Ektodermale Dysplasie

D) Electrodiagnostic / physiologic tests

16. QSART (Quantitative Sudomotor Axon Reflex Test) – A small electrical current and acetylcholine stimulate sweating; sweat volume is measured to assess autonomic sweat function. HED shows reduced/absent response due to gland underdevelopment. NCBI+1

17. Resting skin conductance/galvanic skin response – Noninvasive measurement of sweat-related skin conductivity; reduced changes support impaired sudomotor function, consistent with HED patterns seen on TST/QSART. PMC

18. Core temperature and heart-rate monitoring during controlled heat exposure – Physiologic assessment can document impaired heat dissipation and rapid temperature rise, reinforcing the functional significance of anhidrosis. MDPI

E) Imaging and instrumented tests

19. Dental radiographs (panoramic and periapical) / CBCT when needed – Imaging shows missing tooth buds, root malformations, and jaw space considerations for prosthetic planning; these findings are classic in HED. PMC

20. Meibography / ocular surface metrics (tear breakup time) – Imaging and timed assessments of the tear film demonstrate meibomian/tear abnormalities in those with ocular dryness, supporting gland hypofunction.

Non-pharmacological treatments (therapies & others)

1. Heat-avoidance plan: Keep living spaces cool, use fans/air-conditioning, and avoid hot, humid environments. Purpose is to prevent dangerous overheating. Mechanism is external temperature control because internal sweating is reduced.

2. Active cooling strategies: Cooling vests, misting bottles, cool baths, and ice towels during activity or fevers. Purpose is quick core-temperature reduction. Mechanism is evaporative and conductive heat loss to replace missing sweat cooling.

3. Infant heat safeguards: Never overdress; monitor room temperature; use rectal thermometers during illness; have a clear ER plan for fever. Purpose is to prevent febrile seizures and heat stroke. Mechanism is tight thermal monitoring in those unable to sweat.

4. Hydration routine: Regular fluids, especially in warm weather; small, frequent sips in children. Purpose is to support circulation and cooling. Mechanism is maintaining plasma volume to aid heat dissipation.

5. Early dentures/partial dentures (often by age 3): Restores chewing, speech, and appearance during growth. Mechanism is prosthetic replacement of missing teeth while jaws grow.

6. Age-staged dental plan: Periodic refitting of dentures, orthodontics as needed, and implants only when growth is complete. Purpose is long-term function and facial development. Mechanism is multidisciplinary prosthodontics.

7. Oral hygiene intensification: Fluoridated toothpaste, professional fluoride, flossing, and high-risk caries protocols. Purpose is cavity prevention in dry mouth and abnormal teeth. Mechanism is remineralization and plaque control.

8. Skin care routine: Daily bland emollients and gentle cleansers; manage eczema-like flares. Purpose is to reduce dryness, itching, and infections. Mechanism is barrier restoration.

9. Scalp and hair care: Gentle shampoos; manage seborrheic dermatitis if present; cosmetic hair options or wigs. Purpose is comfort and self-image. Mechanism is symptom relief and cosmetic support.

10. Eye surface care: Artificial tears, lid hygiene, and ophthalmology care for meibomian gland dysfunction. Purpose is to protect the cornea and ease discomfort. Mechanism is tear film support.

11. Nasal/airway care: Humidifiers and saline to reduce crusting and infections; ENT follow-up for recurrent otitis. Mechanism is mucosal hydration and ventilation.

12. Allergy/eczema trigger control: Dust-mite cover, fragrance-free laundry products, and irritant avoidance. Mechanism is reduced barrier irritation in dry skin.

13. School & sports planning: Temperature accommodations, shaded breaks, and nurse action plans. Mechanism is environmental risk control for heat.

14. Fever management plan: Fast medical assessment for fevers; priority cooling while evaluating cause. Mechanism is preventing heat injury during illness.

15. Psychosocial support: Peer groups (e.g., NFED), counseling when needed, and dental appearance support. Mechanism is quality-of-life improvement.

16. Speech/feeding therapy (young children): Helps chewing and early speech when teeth are missing. Mechanism is functional oral adaptation.

17. Sun and skin protection: Broad-spectrum sunscreen, hats; dry skin burns and irritates more easily. Mechanism is barrier and UV protection.

18. Dental treatment centers: Seek multidisciplinary clinics experienced in ectodermal dysplasias for planning and advocacy. Mechanism is specialist coordination.

19. Genetic counseling: Explains inheritance, testing options for relatives, and family planning. Mechanism is risk clarification and informed choices.

20. Clinical-trial awareness (prenatal EDA protein therapy): Investigational intra-amniotic EDA1 replacement improved sweat gland development in small studies; not FDA-approved. Mechanism is developmental pathway rescue during fetal life.

---

Drug treatments

Note: None of the drugs below are FDA-approved for HED itself. They are used to treat common HED-related problems (dry eye, eczema, infections, allergic rhinitis, dry mouth, etc.). Always use under clinician guidance.

Dry eye management

1. Cyclosporine ophthalmic (RESTASIS®): Immunomodulator eye drops that increase tear production in patients with suppressed tear production; typical dose 1 drop OU BID; benefits build over weeks; stinging/burning possible. Class: topical calcineurin inhibitor. Side effects: ocular burning, redness.

2. Lifitegrast ophthalmic (XIIDRA®): LFA-1 antagonist eye drops for signs/symptoms of dry eye; 1 drop OU BID; blocks T-cell adhesion/inflammation; may cause dysgeusia and eye irritation.

Eczema-like skin disease / atopic dermatitis

1. Tacrolimus ointment (PROTOPIC® 0.03/0.1%): Second-line for moderate-severe atopic dermatitis; thin layer BID on flares; steroid-sparing; transient burning possible. Class: topical calcineurin inhibitor.
2. Pimecrolimus cream (ELIDEL® 1%): Mild-moderate atopic dermatitis; thin layer BID; reduces T-cell–driven inflammation; local irritation possible. Class: topical calcineurin inhibitor.
3. Triamcinolone acetonide cream/ointment (various strengths): Topical corticosteroid for inflammatory, itchy dermatoses; use short courses; risks with overuse include skin thinning. Class: corticosteroid.
4. Dupilumab (DUPIXENT®): Biologic for moderate-to-severe atopic dermatitis; loading then Q2W injections; blocks IL-4/IL-13 signaling; conjunctivitis and injection-site reactions may occur. Class: IL-4Rα antagonist.

Skin/ENT infections

1. Mupirocin (BACTROBAN®) ointment/cream 2%: For impetigo/local skin infection; apply TID up to 10 days; minimal systemic absorption. Class: topical antibiotic.
2. Amoxicillin (AMOXIL®): For indicated bacterial ENT/dental infections; dosing varies by infection and weight; watch for allergy. Class: β-lactam antibiotic.
3. Cephalexin (KEFLEX®): For susceptible skin/soft-tissue or ENT infections; oral dosing per label; GI upset possible. Class: first-generation cephalosporin.

Allergic rhinitis / airway dryness with allergy

1. Fluticasone nasal spray (FLONASE®/VERAMYST®): Intranasal corticosteroid QD; reduces nasal inflammation, congestion, and sneezing. Class: corticosteroid.
2. Cetirizine (ZYRTEC®): Oral antihistamine QD for itchy eyes/nose and sneezing; sedation possible. Class: H1 antihistamine.
3. Montelukast (SINGULAIR®): Leukotriene receptor antagonist QD for allergic rhinitis/asthma; boxed warning for serious neuropsychiatric events—use only when benefits outweigh risks. Class: LTRA.

Dry mouth / dental protection

1. Cevimeline (EVOXAC®): Muscarinic agonist that stimulates salivary flow in patients who still have residual gland tissue; 30 mg TID; sweating, flushing, or GI effects can occur. Class: cholinergic agonist.
2. Pilocarpine (SALAGEN®): Muscarinic agonist for xerostomia; 5 mg QID typical; may cause sweating, flushing, urinary frequency—avoid if sweating is dangerous in your climate. Class: cholinergic agonist.
3. Chlorhexidine 0.12% oral rinse (PERIDEX®): Antimicrobial rinse BID to reduce gingivitis and plaque in high-risk mouths; can stain teeth/taste. Class: antimicrobial rinse.
4. Rx fluoride products (e.g., 1.1% sodium fluoride dental cream): High-fluoride home use for caries prevention in high-risk patients per dentist; product-specific labeling varies. Class: topical fluoride.

Seborrheic scalp / dermatitis care

1. Ketoconazole 2% shampoo (NIZORAL® Rx): Antifungal shampoo 2–3×/week for dandruff/seborrheic dermatitis; reduces Malassezia load; local irritation possible. Class: topical imidazole antifungal.

Fever/pain plan (heat-sensitive patients)

1. Ibuprofen oral suspension: For pain/fever with weight-based dosing; avoid dehydration; GI upset or rare renal risk. Class: NSAID.
2. Acetaminophen (paracetamol): For pain/fever; adhere to strict daily max across all products; overdose causes liver injury. Class: analgesic/antipyretic.

Dermatitis adjunct

1. Topical corticosteroid (low-potency, e.g., hydrocortisone 1% Rx/OTC labeling varies): Short courses on limited areas to calm flares under clinician guidance; overuse can thin skin. (Representative FDA corticosteroid label cited above for triamcinolone.)

---

Immunity-booster / regenerative / stem-cell drugs

There are no FDA-approved “immunity-booster,” regenerative, or stem-cell drugs for HED. Listing such drugs for HED would be misleading and unsafe. The only disease-directed approach with promising evidence is prenatal EDA protein replacement (intra-amniotic EDI200), which improved sweat gland development in small studies but remains investigational and not FDA-approved. Families considering this should do so only in the setting of an approved clinical study.

---

Dietary molecular supplements

Use cautiously and discuss with a clinician—evidence is general (skin, mucosa, immunity), not HED-specific.

1. Vitamin D: Supports bone, immune function; check and replete if low; dosing depends on level and age; excessive doses can harm. Mechanism: secosteroid hormone affecting calcium and immune pathways.
2. Zinc: Cofactor for enzymes and skin repair; avoid excess; consider if deficiency or poor diet. Mechanism: supports wound healing and immune cell function.
3. Omega-3 fatty acids (fish oil): Data for eczema prevention/treatment are mixed to modest; may help some with skin inflammation. Mechanism: anti-inflammatory eicosanoid shift.
4. Biotin (B7): Useful mainly in proven deficiency; routine high-dose use can interfere with lab tests—confirm need first. Mechanism: cofactor for fatty-acid and amino-acid metabolism.
5. Hyaluronic acid (oral): Small trials suggest improved skin hydration; use as adjunct only. Mechanism: hydrophilic polysaccharide improving dermal hydration.
6. Vitamin A (within safe intake): Important for epithelial health; avoid excess due to toxicity; discuss prenatal safety. Mechanism: regulates keratinization and mucosal integrity.
7. Vitamin E (within DV): Antioxidant; evidence for eczema is limited; avoid high doses without indication. Mechanism: lipid antioxidant in membranes.
8. Selenium (within DV): Antioxidant enzyme cofactor; deficiency is uncommon; avoid excess. Mechanism: selenoproteins in antioxidant defense.
9. Probiotics (strain-specific): Evidence for eczema is variable; if used, select clinically studied strains and monitor. Mechanism: microbiome/immune modulation.
10. Calcium + Vitamin D (for kids with chewing limits): Supports bone health when diet is restricted; dose per age and labs. Mechanism: bone mineralization support.

---

Surgeries/procedures

1. Early dentures/partials (prosthodontic procedures): Impressions, fabrication, and periodic refitting from preschool age to restore chewing, speech, and appearance. Done because missing teeth impair nutrition and development.
2. Orthodontics/orthognathic planning: Guided eruption, space maintenance, and jaw alignment to prepare for adult prostheses; done to optimize function and facial growth.
3. Dental implants (after growth completion): CBCT-guided placement of implants to anchor prostheses; delayed until skeletal maturity to avoid growth mismatch.
4. ENT procedures (e.g., ear tubes when indicated): For recurrent otitis media due to Eustachian tube dysfunction; done to protect hearing and reduce infections.
5. Ophthalmic procedures (selected): Punctal plugs for severe dry eye unresponsive to drops; performed to conserve tears and protect the cornea.

---

Preventions

1. Cool home, cool school policies for all seasons.

2. Hydration habits built into the day and before/after activity.

3. Rapid fever action plan with antipyretics and cooling.

4. Daily oral hygiene + professional fluoride to prevent cavities.

5. Skin moisturizers right after bathing to lock in water.

6. Allergen/irritant avoidance to reduce eczema flares.

7. Eye lubrication routine to prevent corneal damage.

8. Vaccinations per schedule to prevent respiratory infections.

9. Dentist experienced in ED with a staged treatment roadmap.

10. Genetic counseling for family planning and early baby safeguards.

---

When to see a doctor (red flags)

Seek urgent care for fever that is hard to control, lethargy, confusion, fainting, or signs of heat stroke (hot, dry skin; rapid heartbeat; dizziness). See specialists promptly for eye pain/redness, recurrent ear or sinus infections, painful skin infection, and feeding or speech problems related to missing teeth. Babies with HED need early pediatric and dental visits to set up cooling and nutrition plans, plus referral for genetic testing.

---

What to eat & what to avoid

Eat: soft, nutrient-dense foods if chewing is hard (eggs, yogurt, lentils, soft fruits/vegetables), adequate protein for growth, calcium- and vitamin-D–rich foods for bones, and plenty of fluids (water, oral rehydration in heat). These choices support growth, oral tissues, and hydration.

Avoid or limit: very hard, sticky candies and constant sugary snacks/drinks (cavity risk), caffeinated diuretics when overheated, and excess vitamin supplements without medical guidance (toxicity risks, lab interferences—biotin).

---

FAQs

1) Is there a cure for HED?
No FDA-approved cure exists. Care focuses on cooling, dental, skin, eye, and infection management. Prenatal EDA protein therapy is investigational.

2) Why do people with HED overheat?
They have few or no working sweat glands, so the body cannot cool by evaporation.

3) How is HED diagnosed?
By clinical features plus genetic testing (EDA, EDAR, EDARADD, WNT10A).

4) Do women get HED?
Yes. Females with X-linked variants can have milder, patchy findings; autosomal forms affect all sexes.

5) Can my child get dentures before school?
Yes. Many children successfully use dentures around age 3; plans evolve as they grow.

6) Are dental implants possible?
Usually after growth is complete; CBCT and a team plan are needed.

7) Are there medicines for dry eyes?
Yes—cyclosporine and lifitegrast drops improve tear function and symptoms in selected patients.

8) Will eczema go away?
It can be managed with moisturizers, topical anti-inflammatories, and biologics for moderate-severe disease.

9) Are “immune boosters” or stem-cell drugs used for HED?
No. There are no FDA-approved immune-boosting, regenerative, or stem-cell drugs for HED.

10) Which specialists should we see?
Pediatrics/family medicine, dentistry/prosthodontics, dermatology, ophthalmology, ENT/allergy, and genetics.

11) What dental X-rays are needed?
Panoramic radiographs show tooth buds and missing teeth; used for planning.

12) How do we test sweating?
Simple starch–iodine mapping and formal sudomotor tests can show lack of sweating.

13) Is overheating an emergency?
Yes—cool immediately and seek medical care. Children are especially vulnerable.

14) Will HED affect school or sports?
With heat accommodations, hydration, and cooling gear, most children participate safely.

15) Where can we find expert resources?
The National Foundation for Ectodermal Dysplasias (NFED) offers guides, treatment centers, and support groups.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: October 02, 2025.